Source: Clinics. Unidades: FM, ICB
Subjects: MICROBIOLOGIA, COVID-19, ANTÍGENOS DE VÍRUS, ELISA, IMUNOGLOBULINAS, PROTEÍNAS RECOMBINANTES, REAÇÃO EM CADEIA POR POLIMERASE, PACIENTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EKMAN, Luciana Regina Meireles Jaguaribe et al. Natural versus recombinant viral antigens in SARS-CoV-2 serology: challenges in optimizing laboratory diagnosis of COVID-19. Clinics, v. 75, p. 7 , 2020Tradução . . Disponível em: https://doi.org/10.6061/clinics/2020/e2290. Acesso em: 28 abr. 2024.APA
Ekman, L. R. M. J., Silva, A. M. I. F. da, Carvalho, C. A. de, Kesper, N., Galisteo Junior, A. J., Soares, C. P., et al. (2020). Natural versus recombinant viral antigens in SARS-CoV-2 serology: challenges in optimizing laboratory diagnosis of COVID-19. Clinics, 75, 7 . doi:10.6061/clinics/2020/e2290NLM
Ekman LRMJ, Silva AMIF da, Carvalho CA de, Kesper N, Galisteo Junior AJ, Soares CP, Araujo DB, Durigon EL, Durigon DBL de O, Morganti L, Chambi RMC, Andrade Junior HF de. Natural versus recombinant viral antigens in SARS-CoV-2 serology: challenges in optimizing laboratory diagnosis of COVID-19 [Internet]. Clinics. 2020 ; 75 7 .[citado 2024 abr. 28 ] Available from: https://doi.org/10.6061/clinics/2020/e2290Vancouver
Ekman LRMJ, Silva AMIF da, Carvalho CA de, Kesper N, Galisteo Junior AJ, Soares CP, Araujo DB, Durigon EL, Durigon DBL de O, Morganti L, Chambi RMC, Andrade Junior HF de. Natural versus recombinant viral antigens in SARS-CoV-2 serology: challenges in optimizing laboratory diagnosis of COVID-19 [Internet]. Clinics. 2020 ; 75 7 .[citado 2024 abr. 28 ] Available from: https://doi.org/10.6061/clinics/2020/e2290